http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202214254-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a0c3e4b714908382e152c4ee0b8ed0b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae4a3be5e6607410d07badff8cce5bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b97238619b1337be100c8cebe6e0924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f7df3f376576328e8b6a316b5f2a48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e748ddfd3247d354d366753064436656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fdb8e81ffe7ad1737dac55ec4b5fa0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cabd17ed59e613fd3c4449097bdefeb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6849d91c7c56bcb52b789ed188f69f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e492e8b90dc62cca768edf9784067f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d0f258d09c8085c674194e02b6c31a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1394b17c6e0d889f5cab58e079e53252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b224c450a56f3a78082330014e47e650
publicationDate 2022-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202214254-A
titleOfInvention USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kδ RELATED DISORDERS
abstract The present application provides methods of treating PI3Kδ related disorders using compounds of Formula I:n or pharmaceutically acceptable salts thereof.
priorityDate 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21083976

Total number of triples: 28.